Jailendra Singh
Stock Analyst at Truist Securities
(0.88)
# 3,664
Out of 4,829 analysts
170
Total ratings
26.97%
Success rate
-25.47%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAY Waystar Holding | Maintains: Buy | $45 → $50 | $40.01 | +24.97% | 2 | May 8, 2025 | |
| MEDP Medpace Holdings | Maintains: Hold | $333 → $300 | $299.21 | +0.26% | 4 | Apr 23, 2025 | |
| IQV IQVIA Holdings | Maintains: Buy | $263 → $216 | $148.99 | +44.98% | 15 | Apr 10, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $262 → $208 | $133.96 | +55.27% | 9 | Apr 10, 2025 | |
| PRVA Privia Health Group | Maintains: Buy | $27 → $28 | $25.02 | +11.91% | 7 | Apr 10, 2025 | |
| HIMS Hims & Hers Health | Maintains: Hold | $39 → $33 | $51.96 | -36.49% | 9 | Apr 10, 2025 | |
| GDRX GoodRx Holdings | Maintains: Hold | $6.5 → $5.5 | $4.32 | +27.31% | 12 | Apr 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $15 → $14 | $9.05 | +54.70% | 5 | Apr 10, 2025 | |
| DOCS Doximity | Maintains: Hold | $65 → $58 | $59.19 | -2.01% | 7 | Apr 10, 2025 | |
| AMWL American Well | Maintains: Hold | $12 → $7.5 | $6.84 | +9.65% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $46 | $29.71 | +54.83% | 5 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $261 → $210 | $237.05 | -11.41% | 7 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $34 | $25.62 | +32.71% | 5 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $26 → $19 | $21.19 | -10.34% | 9 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $10 | $7.11 | +40.65% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.77 | +9.63% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $2.89 | +124.91% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $5.12 | +153.91% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $7.01 | +513.41% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $3.69 | +550.41% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $2.67 | +49.81% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $148.22 | -60.87% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $8.20 | +448.78% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $693.46 | -51.98% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.51 | +156.41% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $23.07 | - | 3 | Jan 15, 2021 |
Waystar Holding
May 8, 2025
Maintains: Buy
Price Target: $45 → $50
Current: $40.01
Upside: +24.97%
Medpace Holdings
Apr 23, 2025
Maintains: Hold
Price Target: $333 → $300
Current: $299.21
Upside: +0.26%
IQVIA Holdings
Apr 10, 2025
Maintains: Buy
Price Target: $263 → $216
Current: $148.99
Upside: +44.98%
ICON Public Limited Company
Apr 10, 2025
Maintains: Buy
Price Target: $262 → $208
Current: $133.96
Upside: +55.27%
Privia Health Group
Apr 10, 2025
Maintains: Buy
Price Target: $27 → $28
Current: $25.02
Upside: +11.91%
Hims & Hers Health
Apr 10, 2025
Maintains: Hold
Price Target: $39 → $33
Current: $51.96
Upside: -36.49%
GoodRx Holdings
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $4.32
Upside: +27.31%
Evolent Health
Apr 10, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $9.05
Upside: +54.70%
Doximity
Apr 10, 2025
Maintains: Hold
Price Target: $65 → $58
Current: $59.19
Upside: -2.01%
American Well
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $6.84
Upside: +9.65%
Mar 18, 2025
Maintains: Buy
Price Target: $50 → $46
Current: $29.71
Upside: +54.83%
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $237.05
Upside: -11.41%
Dec 11, 2024
Maintains: Buy
Price Target: $31 → $34
Current: $25.62
Upside: +32.71%
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $21.19
Upside: -10.34%
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $7.11
Upside: +40.65%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.77
Upside: +9.63%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $2.89
Upside: +124.91%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $5.12
Upside: +153.91%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $7.01
Upside: +513.41%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $3.69
Upside: +550.41%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $2.67
Upside: +49.81%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $148.22
Upside: -60.87%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $8.20
Upside: +448.78%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $693.46
Upside: -51.98%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.51
Upside: +156.41%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $23.07
Upside: -